EP3410874

ABBOTT LABORATORIES
Application Number
EP17703302A
Filing Date
Jan 25, 2017
Status
Revoked
Mar 1, 2024
Grant Date
May 5, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3410874B1 was granted on May 5, 2021 by Abbott Laboratories The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SOCIETE DES PRODUITS NESTLE S.A.Feb 7, 2022ADMISSIBLE
FRESENIUS KABI DEUTSCHLAND GMBHFeb 4, 2022ADMISSIBLE

The table below shows the patents of Abbott Laboratories that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2658399Nutritional Compositions Comprising Human Milk Oligosaccharides And Nucleotides And Uses Thereof For Treating And/Or Preventing Enteric Viral InfectionFeb 28, 20242
EP3436822Decision Tree Based Systems And Methods For Estimating The Risk Of Acute Coronary SyndromeOct 18, 20231
EP3599898Liquid Nutritional Compositions Containing Oxidizable Fish Oil, Rosmarinic Acid And Ferric IronAug 17, 20221

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.